Skip Navigation LinksHome > July 2014 - Volume 22 - Issue 4 > Safety and Tolerability of Double-Dose and Duration Oseltami...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0000000000000126
Original Articles

Safety and Tolerability of Double-Dose and Duration Oseltamivir Regimens in Patients with H1N1pdm09

Cupelli, Lisa PhD*; Bailony, Mohammed MD; Burgess, Tracy MSc; Dutkowski, Regina PhD§

Supplemental Author Material
Collapse Box


Background: A novel influenza A/H1N1 virus (H1N1pmd09) emerged in April 2009. To address concerns about the suitability of standard oseltamivir regimens for controlling the virus, a randomized trial was initiated to explore virologic responses to standard and nonstandard regimens in patients infected with H1N1pdm09.

Methods: Patients aged 1 year and older with influenza-like illness and a positive rapid test result for influenza A were eligible for enrollment. Adults received 75 mg or 150 mg of oseltamivir twice daily for 5 or 10 days; children received weight-based unit-dose equivalents. Assessments included viral shedding and resistance testing; symptoms were recorded in patients’ diaries and adverse events (AEs) were recorded during patient visits.

Results: When the pandemic was declared over, the study was closed prematurely and therefore did not meet its recruitment target. A total of 102 patients were enrolled, with 101 included in the safety population and 70 in the intent-to-treat infected population. The sample size prevented meaningful evaluation of virologic responses to the investigational regimens. No resistant viruses were isolated at baseline, and treatment-emergent resistance was detected in 2 (3.2%) of 63 patients with positive virology test results. All of the regimens were generally well tolerated, with most on-treatment AEs considered unrelated or remotely related to treatment. No serious AEs or deaths were reported.

Conclusions: In the current study, treatment-emergent resistance was uncommon and all of the oseltamivir regimens were well tolerated in children and adults.

© 2014 by Lippincott Williams & Wilkins.

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.